These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 12905100)
41. Psychotropic drug prescription in a psychiatric university hospital. Voirol P; Robert PA; Meister P; Oros L; Baumann P Pharmacopsychiatry; 1999 Jan; 32(1):29-37. PubMed ID: 10071180 [TBL] [Abstract][Full Text] [Related]
42. Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns. Apiquian R; Fresán A; de la Fuente-Sandoval C; Ulloa RE; Nicolini H BMC Psychiatry; 2004 Apr; 4():12. PubMed ID: 15109398 [TBL] [Abstract][Full Text] [Related]
43. Clinical and social determinants of long-term use of benzodiazepines and its impact on quality of life of Chinese schizophrenia patients. Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS Pharmacopsychiatry; 2007 Nov; 40(6):269-74. PubMed ID: 18030651 [TBL] [Abstract][Full Text] [Related]
44. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia. Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734 [TBL] [Abstract][Full Text] [Related]
45. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review]. Khaldi S; Kornreich C; Choubani Z; Gourevitch R Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460 [TBL] [Abstract][Full Text] [Related]
46. Variation in prescribing of hypnotics, anxiolytics and antidepressants between 61 general practices. Pharoah PD; Melzer D Br J Gen Pract; 1995 Nov; 45(400):595-9. PubMed ID: 8554839 [TBL] [Abstract][Full Text] [Related]
47. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors. Sankaranarayanan J; Puumala SE Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297 [TBL] [Abstract][Full Text] [Related]
48. Clinical correlates of antipsychotic polytherapy in patients with schizophrenia in Singapore. Sim K; Su A; Chan YH; Shinfuku N; Kua EH; Tan CH Psychiatry Clin Neurosci; 2004 Jun; 58(3):324-9. PubMed ID: 15149301 [TBL] [Abstract][Full Text] [Related]
49. Addition of antipsychotics to medication regimens during schizophrenic inpatient care. Koyama A; Ito H; Nakanishi M; Sawamura K; Higuchi T Psychiatry Clin Neurosci; 2008 Feb; 62(1):56-64. PubMed ID: 18289142 [TBL] [Abstract][Full Text] [Related]
50. Analysis of clinical characteristics and antipsychotic medication prescribing practices of first-episode schizophrenia in Israel: a naturalistic prospective study. Strous RD; Bar F; Keret N; Lapidus R; Kosov N; Chelben J; Kotler M Isr J Psychiatry Relat Sci; 2006; 43(1):2-9. PubMed ID: 16910378 [TBL] [Abstract][Full Text] [Related]
51. Prescribing habits for psychiatric in-patient admissions in a Nigerian psychiatric hospital. Adamson TA Afr J Med Med Sci; 1995 Sep; 24(3):261-7. PubMed ID: 8798962 [TBL] [Abstract][Full Text] [Related]
52. [Measures to reduce high-dose multiple antipsychotics in Japan]. Sukegawa T Seishin Shinkeigaku Zasshi; 2012; 114(6):696-701. PubMed ID: 22844821 [TBL] [Abstract][Full Text] [Related]
53. Patient factors associated with receipt of combination antipsychotic drug therapy in the treatment of schizophrenia. Hayhurst KP; Drake RJ; Lewis SW J Psychopharmacol; 2010 Jan; 24(1):83-9. PubMed ID: 18719041 [TBL] [Abstract][Full Text] [Related]
54. Prescription patterns for psychotropic drugs in cancer patients; a large population study in the Netherlands. Ng CG; Boks MP; Smeets HM; Zainal NZ; de Wit NJ Psychooncology; 2013 Apr; 22(4):762-7. PubMed ID: 22351591 [TBL] [Abstract][Full Text] [Related]
55. Epidemiology of prescriptions for neuroleptic drugs: tranquilizers rather than antipsychotics. Linden M; Thiels C Pharmacopsychiatry; 2001 Jul; 34(4):150-4. PubMed ID: 11518477 [TBL] [Abstract][Full Text] [Related]
56. Use of anticholinergic drugs in patients with schizophrenia in Asia from 2001 to 2009. Xiang YT; Wang CY; Si TM; Lee EH; He YL; Ungvari GS; Chiu HF; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong KH; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N Pharmacopsychiatry; 2011 May; 44(3):114-8. PubMed ID: 21491361 [TBL] [Abstract][Full Text] [Related]
57. Trends in treatment of newly treated schizophrenia-spectrum disorder patients in Taiwan from 1999 to 2006. Wu CS; Lin YJ; Feng J Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):989-96. PubMed ID: 22416032 [TBL] [Abstract][Full Text] [Related]
58. A prospective survey on drug choice for prescriptions for admitted patients with schizophrenia. Ito C; Kubota Y; Sato M Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S35-40. PubMed ID: 10560896 [TBL] [Abstract][Full Text] [Related]
59. Drug prescription patterns in schizophrenia outpatients: analysis of data from a German health insurance fund. Weinbrenner S; Assion HJ; Stargardt T; Busse R; Juckel G; Gericke CA Pharmacopsychiatry; 2009 Mar; 42(2):66-71. PubMed ID: 19308881 [TBL] [Abstract][Full Text] [Related]
60. [The trend for megadose polypharmacy in antipsychotic pharmacotherapy: a prescription survey conducted by the psychiatric clinical pharmacy research group]. Yoshio T Seishin Shinkeigaku Zasshi; 2012; 114(6):690-5. PubMed ID: 22844820 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]